131177-53-2

Basic information

• Product Name: (R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE
• Synonyms: D-AP6;D(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID;(R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE;(R)-(-)-2-Amino-6-phosphonohexanoicacidhydrate,e.e.;6-Phosphono-D-norleucine.;(R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE 95% (97% E.E.);(R)-(-)-2-Amino-6-phosphonohexanoic acid hydrate, 97% ee;BING2
• CAS NO: 131177-53-2
• Molecular Formula: C6H14NO5P
• Molecular Weight: 211.15
• Mol File: 131177-53-2.mol

Chemical Properties

• Melting Point: 215-220 °C
• Boiling Point: 479.3 °C at 760 mmHg
• Flash Point: 243.6 °C
• Appearance: white hygroscopic powder
• Density: 1.452 g/cm³
• Vapor Pressure: 1.67E-10mmHg at 25°C
• Storage Temp.: -20°C
• CAS DataBase Reference: (R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE(131177-53-2)
• EPA Substance Registry System: (R)-(-)-2-AMINO-6-PHOSPHONOHEXANOIC ACID HYDRATE(131177-53-2)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26-36
• Hazardous Substances Data: 131177-53-2(Hazardous Substances Data)

Usage

Chemical Properties

white fine crystalline powder

InChI:InChI=1/C6H14NO5P/c7-5(6(8)9)3-1-2-4-13(10,11)12/h5H,1-4,7H2,(H,8,9)(H2,10,11,12)/p-2/t5-/m1/s1

Upstream product

• 114967-67-8 (N-acetylamino-5 bis-ethoxycarbonyl-5,5)-pentylphosphonate de diethyle 
• 137622-47-0 2-Acetylamino-2-(4-phosphono-butyl)-malonic acid diethyl ester 
• 5183-27-7 6-bromo-2-acetamido-2-ethoxycarbonyl-hexanoic acid ethyl ester 
• 78944-89-5 6-Phosphono-DL-norleucine 
• 57591-61-4 methyl (R)-2-amino-2-(4-hydroxyphenyl)acetate hydrochloride 

Relevant articles and documents

OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINOPHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE

A novel compound has pharmacological activities comparable to those of Nahlsgen and is storable excellently stably. The compound can be produced by a method according to the present invention for producing an optically active 2-amino-phosphonoalkanoic acid salt. In the method, a starting material DL-2-amino-phosphonoalkanoic acid represented by Formula (1) or a hydrate thereof is reacted with an optically active basic compound other than an optically active lysine, to give a diastereomeric salt mixture including a first salt (including a hydrate salt) between a D-2-amino-phosphonoalkanoic acid represented by Formula (1-1) and the optically active basic compound, and a second salt (including a hydrate salt) between an L-2-amino-phosphonoalkanoic acid represented by Formula (1-2) and the optically active basic compound. The diastereomeric salt mixture is fractionally crystallized to isolate one of the first and second diastereomeric salts.

Involucrin gene expression promoter

PROBLEM TO BE SOLVED: To provide an involucrin gene expression promoter that has high effect of promoting involucrin gene expression, and is applied to the skin, to quickly increase involucrin concentrations, and markedly improving the barrier function. SOLUTION: An involucrin gene expression promoter contains at least one selected from a compound represented by the following formula (1) [where R1 and R2 are the same or different to represent a hydrogen atom, or a substituent. n is an integer of 1 or greater], a salt thereof, and their hydrates as an active ingredient. SELECTED DRAWING: None COPYRIGHT: (C)2019,JPO&INPIT

Enantioselective synthesis of both enantiomers of 2-amino-6-phosphonohexanoic acid [(R)- and (S)-AP6], a potent and specific agonist of AMPA receptor subtype

The preparation of both enantiomers of 2-amino-6-phosphonohexanoic acid [(R)- and (S)-AP6] is described. The highly diastereoselective alkylation of imidazolidinones 4 and hydrolysis of the alkylated products [(2R,5R,1'S)-6 and (2S,5S,1'S)-6] proceeds under relatively mild conditions to give the physiologically important, enantiopure aminophosphonic acids (R)-AP6 and (S)-AP6.

Phosphorus-containing aminocarboxylic acids. VII. Asymmetric synthesis of ω-phosphono-α-aminocarboxylic acids

New asymmetric ω-phosphono-α-aminocarboxylic acids were synthesized by alkylation with ω-bromoalkylphosphonates of the glycine methylene group in the Ni(II) complex of the Schiff base derived from glycine and (S)- and (R)-2-N-(N-benzylprolyl)-o-aminobenzo

PHOSPHORUS-CONTAINING AMINOCARBOXYLIC ACIDS. COMMUNICATION IV. A CONVENIENT METHOD OF PHOSPHONIC ACIDS SYNTHESIS

The communication is concerned with the synthesis of phosphonic aminocarboxylic acids by phosphorylation of diethyl ω-halogen alkyl acetamidomalonates with tris(trimethylsilyl) phosphite, followed by alcoholysis and acid hydrolysis of the resulting intermediate esters.Key words: Phosphonic aminocarboxylic acids; tris(trimethylsilyl) phosphite; ω-halogenalkyl acetamidomalonates; phosphorylation; alcoholysis, hydrolysis

SYNTHESE D'ACIDES ω-AMINO-ω-CARBOXY-ALKYLPHOSPHONIQUES

ω-Amino ω-carboxyalkylphosphonic acids 1 synthesis is reviewed.For n = 4, 5, 6 a general, efficient and inexpensive synthesis is described; acetamido(ω-bromoalkyl)malonates 12 are prepared from commercial dibromoalkanes and acetamidomalonate using the phase transfer catalysis process, then condensed with triethylphosphite through an Arbuzov reaction.An acid hydrolysis followed by purification on Dowex gives aminophosphonic acids 1 (n = 4, 5, 6) with a 70percent overall yield.The lower acid 1 (n = 2) is obtained with an identical overall yield from acetamidomalonate and 2-haloethylphosphonate using also liquid-solid phase transfer catalysis.